Ryan Bethencourt

Ryan Bethencourt is a scientist, entrepreneur, and investor best known for his work as co-founder and venture partner at IndieBio. Ryan is one of the 21st century’s most prolific biotech investors and entrepreneurs through his work funding and building over 70+ biotech companies over the last decade. Ryan is also a Partner at BABEL Ventures and faculty member at Singularity, focused on harnessing biology as a technology to solve of the world’s most intractable problems. He was previously head of life sciences at XPRIZE Foundation, the former CEO of Berkeley Biolabs and spent a decade developing human therapeutic with large companies like Pfizer, Merck, Amgen, Genentech. Ryan has funded and helped build include, Future of Food (Ava Labs, Memphis Meats, Clara Foods, Geltor, Miraculex, Finless Foods, The NotCo., SugarLogix), Medicine (Orphidia, SyntheX, QIDNI labs, Neuroqore, Ravata, Venomyx Therapeutics, Scaled Biolabs, GEA Enzymes, Mendel.ai, Bioaesthetics, Proteorex, Prellis Biologics, DNA lite, QuantumCyte), Biological Computation (Koniku, Catalog Technologies), Consumer Biotech (NERD Skincare, Amino labs, Mycoworks, Animal Biome), Environmental (Pembient, Bioinspira, UBA Biologics). Ryan has a BSs degree in Biological Sciences (Molecular Genetics) from Warwick University, a joint Masters in Bioscience Enterprise (MBE) from Cambridge University and MIT. He’s also been a Doctor of Philosophy (PhD) Candidate at the Center for Regenerative Medicine at the University of Edinburgh before pivoting to build startups.